Actavis Inc - ACT - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Actavis Inc - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
ACT	New York	2834	http://www.actavis.com	124.50 -1.17
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Actavis Inc InPlay: Actavis And Kissei file lawsuits against sandoz and hetero for infringement of rapaflo patent - Jun 19th, 2013 6:04 am Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo® Patent - Jun 19th, 2013 6:00 am Lundbeck Fined $125.6 Million by EU Drug Delay Probe - Jun 19th, 2013 3:30 am Supreme Court satisfies few with ruling on generic drug settlements - Jun 18th, 2013 3:30 pm "Pay-For Delay" Was Fun While It Lasted - Jun 18th, 2013 2:30 pm Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition - Jun 18th, 2013 2:18 pm [video] Go All-In On Actavis, Visa - Jun 18th, 2013 9:22 am Cramer's Mad Money - Where The Fed Stops, Nobody Knows (6/17/13) - Jun 18th, 2013 4:47 am Arnold & Porter, Skadden, Cravath, Willkie: Business of Law - Jun 17th, 2013 10:01 pm ACTAVIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits - Jun 17th, 2013 9:01 pm [video] An Anti-Competitive Decision? - Jun 17th, 2013 5:44 pm Cramer Makes the Case for M&A - Jun 17th, 2013 4:58 pm [video] Stocks Higher on M&A Deals - Jun 17th, 2013 4:45 pm Drugmakers Opened to ‘Pay for Delay’ Suits by High Court - Jun 17th, 2013 3:44 pm Simcere Ties Up with Bristol-Myers - Jun 17th, 2013 3:20 pm Label Expansion for Astellas Drug - Jun 17th, 2013 2:50 pm Court: 'Pay to delay' generic drugs can be illegal - Jun 17th, 2013 2:33 pm Court: 'Pay to delay' generic drugs can be illegal - Jun 17th, 2013 2:32 pm High Court's Generic Drug Ruling 'a Holy Mess' - Jun 17th, 2013 1:58 pm ViroPharma Stock Jumps On Buyout Rumors - Jun 17th, 2013 11:58 am View All Current Headlines >>